Weekly shot cut knee osteoarthritis pain and body weight in two large trials
☕ Includes a question for the family ↓
Knee osteoarthritisPart of a story we are following · 4 articles · See every update
If sore knees have slowed down your walks, this research is worth a look. In two trials with 445 and 574 adults who had painful knee osteoarthritis and obesity, people who took the once-weekly shot retatrutide had much less knee pain than people on placebo, and those on the 9 mg dose lost about 20% of their body weight.
Retatrutide is still an investigational drug, so you can’t get it at the pharmacy yet. Still, the results show that treating weight and knee pain together can bring a real, noticeable change.
How the study worked
These were two phase 3 randomized trials, called TRIUMPH-4 and TRIUMPH-1-OA. Adults without diabetes, with painful knee osteoarthritis and a body-mass index of at least 27, were randomly assigned to a weekly injection of retatrutide or a placebo, for 68 weeks in one trial and 80 weeks in the other. The results were published in the N Engl J Med on November 8, 2026, and the trials were funded by Eli Lilly, the drug’s maker. The drug is still being tested and the trials only included adults without diabetes, so the results speak to that group.
What did the researchers find?
Pain was measured on a 0 to 10 scale, where higher means worse pain. Everyone’s pain dropped a bit, even on placebo. But the drop was much bigger with the drug.
In TRIUMPH-4, after 68 weeks, pain fell by about 4 points on average with retatrutide (3.96 points on the 9 mg dose and 3.74 on the 12 mg dose). On placebo, it fell by about 2 points (2.12). That is a gap of about 2 points, or 1.83 points exactly for the 9 mg dose.
Weight changed a lot too. People on retatrutide lost 20.0% of their body weight on the 9 mg dose and 23.7% on the 12 mg dose. People on placebo lost 4.6%.
In TRIUMPH-1-OA, after 80 weeks, pain dropped by 3.22 points on the 4 mg dose, 3.48 on the 9 mg dose and 3.64 on the 12 mg dose. Placebo dropped 1.87. Every dose beat placebo, including the lowest one.
The most common side effects were stomach and gut problems. Serious side effects were also more common with retatrutide than with placebo. That is part of the full picture and a good reason this drug is being studied carefully before anyone can prescribe it.
What does the pain score mean?
The pain score in this study is called WOMAC. It asks people how much their knee hurts during everyday things, like walking or climbing stairs, and turns the answers into a number from 0 to 10. A drop of several points means everyday movements hurt noticeably less. That is why a change of about 4 points, compared with about 2 on placebo, stood out to the researchers.
What you can do today
Start your own simple knee log. Once a week, on the same day, rate your knee pain from 0 to 10 in the notes app on your phone, and add a few words about what you did that week, like walking, stairs or gardening. After a month or two, you will see your own patterns, and you will have clear information to share at your next checkup.
Talk about it at home
Your knee works a bit like a door hinge, with a soft pad between the bones so they glide instead of scrape. Scientists wanted to know if a new medicine could help sore knees, so they gave it to some volunteers and a look-alike pretend medicine to others. Then they compared how the two groups felt.
Try it at home
Look up how a knee joint works together and find the name of the soft cushion between the bones.
Keep exploring
Copies this article and its questions so you can paste them into ChatGPT, Claude, Gemini or the AI you use, and keep the conversation going.
Cite this article
Mongevity Desk. Weekly shot cut knee osteoarthritis pain and body weight in two large trials. Mongevity. Published November 10, 2026. Accessed November 22, 2026. https://mongevity.science/muscle-and-bone/2026/11/retatrutide-weekly-shot-knee-osteoarthritis-pain-weight/Mongevity Desk. Weekly shot cut knee osteoarthritis pain and body weight in two large trials [Internet]. Mongevity; 2026 Nov 10 cited 2026 Nov 22]. Available from: https://mongevity.science/muscle-and-bone/2026/11/retatrutide-weekly-shot-knee-osteoarthritis-pain-weight/Mongevity Desk. (2026, November 10). Weekly shot cut knee osteoarthritis pain and body weight in two large trials. Mongevity. https://mongevity.science/muscle-and-bone/2026/11/retatrutide-weekly-shot-knee-osteoarthritis-pain-weight/
<a href="https://mongevity.science/muscle-and-bone/2026/11/retatrutide-weekly-shot-knee-osteoarthritis-pain-weight/">Weekly shot cut knee osteoarthritis pain and body weight in two large trials</a>
Free to share or quote with credit and a link.
Questions and answers
- Can I get retatrutide at the pharmacy?
- No. Retatrutide is an investigational drug, which means it is still being tested and is not yet available as a prescription.
- How much did knee pain drop in the study?
- In one trial, pain on a 0 to 10 scale fell by 3.96 points with the 9 mg dose after 68 weeks. Placebo fell by 2.12 points.
- How much weight did people lose?
- After 68 weeks, people lost 20.0% of their body weight on the 9 mg dose and 23.7% on the 12 mg dose. Placebo was 4.6%.
- What were the side effects?
- The most common ones were stomach and gut problems. Serious side effects were also more common with retatrutide than with placebo.


